| DWS ESG BIOTECH FC | RVI BIOTECNOLOGÍA | 43,97% | 51,14% | 40,78% | · |
| GOLDMAN SACHS MULTI-MANAGER EMERGING MARKETS EQUITY PORTFOLIO R DIS USD | RVI EMERGENTES | 43,97% | 72,56% | 36,26% | 106,16% |
| PICTET - JAPANESE EQUITY OPPORTUNITIES HP EUR | RVI JAPÓN | 43,97% | 84,86% | 123,75% | 272,19% |
| JANUS HENDERSON HF - GLOBAL TECHNOLOGY LEADERS A2 GBP | RVI TECNOLOGÍA | 43,96% | 119,65% | 113,97% | 548,09% |
| JANUS HENDERSON HF - GLOBAL TECHNOLOGY LEADERS X2 USD | RVI TECNOLOGÍA | 43,96% | 116,43% | 108,11% | 515,43% |
| MSIF JAPANESE EQUITY Z (JPY) | RVI JAPÓN | 43,96% | 99,06% | 118,20% | · |
| DWS INVEST ESG EMERGING MARKETS TOP DIVIDEND TFD | RVI EMERGENTES VALOR | 43,95% | 66,98% | 35,41% | · |
| GOLDMAN SACHS US SMALL CAP CORE EQUITY PORTFOLIO P (SNAP) USD CAP | RVI USA SMALL/MID CAP | 43,95% | 73,75% | 76,68% | 201,35% |
| M&G (LUX) ASIAN FUND EUR C ACC | RVI ASIA EX-JAPÓN | 43,95% | 91,76% | 93,78% | 201,86% |
| MFS MERIDIAN ASIA EX-JAPAN FUND C1-USD | RVI ASIA EX-JAPÓN | 43,94% | 59,00% | 26,28% | 97,64% |
